Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated DiseaseClaire L. Langrish, Philip A. Nunn|The Journal of Immunology|2021Cited by 121
Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceusElizabeth C. Goodale, Catherine A. Outerbridge, Petra Bizikova et al.|Veterinary Dermatology|2020Cited by 26